(Q38217657)

English

The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.

scientific article published on 04 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Kenneth K Tanabe

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

0 references

publication date

4 June 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

120

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2824-2838

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Predictors and patterns of recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Understanding surgical decision making in early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Randomized controlled trial of screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Diagnostic imaging of hepatocellular carcinoma: recent progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Extrahepatic Metastases of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prospective validation of the Barcelona Clinic Liver Cancer staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Resection and liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

World review of laparoscopic liver resection-2,804 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Image-guided liver surgery: intraoperative projection of computed tomography images utilizing tracked ultrasound.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Evolution of image-guided liver surgery: transition from open to laparoscopic procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Results of liver transplantation: with or without Milan criteria?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

New trends and novel treatment for hepatocellular carcinoma: a global perspective.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

"Infectious" optimism for treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative portal vein embolization for major liver resection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28730

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38217657&oldid=1873265569"